JP2022531088A5 - - Google Patents
Info
- Publication number
- JP2022531088A5 JP2022531088A5 JP2021561745A JP2021561745A JP2022531088A5 JP 2022531088 A5 JP2022531088 A5 JP 2022531088A5 JP 2021561745 A JP2021561745 A JP 2021561745A JP 2021561745 A JP2021561745 A JP 2021561745A JP 2022531088 A5 JP2022531088 A5 JP 2022531088A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962842197P | 2019-05-02 | 2019-05-02 | |
| US62/842,197 | 2019-05-02 | ||
| PCT/US2020/031332 WO2020223728A1 (en) | 2019-05-02 | 2020-05-04 | Substituted pyrrolopyridines as jak inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022531088A JP2022531088A (ja) | 2022-07-06 |
| JPWO2020223728A5 JPWO2020223728A5 (https=) | 2023-04-14 |
| JP2022531088A5 true JP2022531088A5 (https=) | 2023-04-14 |
Family
ID=73017367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561745A Pending JP2022531088A (ja) | 2019-05-02 | 2020-05-04 | Ｊａｋ阻害剤としての置換ピロロピリジン |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11420966B2 (https=) |
| EP (1) | EP3962897A4 (https=) |
| JP (1) | JP2022531088A (https=) |
| KR (1) | KR20220004726A (https=) |
| CN (1) | CN113727975A (https=) |
| AU (1) | AU2020265828A1 (https=) |
| BR (1) | BR112021021477A2 (https=) |
| CA (1) | CA3138544A1 (https=) |
| IL (1) | IL287717A (https=) |
| MX (1) | MX2021013224A (https=) |
| PH (1) | PH12021552036A1 (https=) |
| SG (1) | SG11202108927UA (https=) |
| WO (1) | WO2020223728A1 (https=) |
| ZA (1) | ZA202105837B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3710431A4 (en) | 2017-11-03 | 2021-07-07 | Aclaris Therapeutics, Inc. | SUBSTITUTED PYRROLOPYRIMIDINE-BASED JAK INHIBITORS AND THEIR MANUFACTURING AND USE PROCEDURES |
| WO2020033955A1 (en) | 2018-08-10 | 2020-02-13 | Aclaris Therapeutics, Inc. | Pyrrolopyrimidine itk inhibitors |
| KR102737181B1 (ko) * | 2019-03-14 | 2024-12-02 | 상하이 시너지 파마슈티컬 사이언시스 코., 엘티디. | Jak 억제제 및 그 제조방법과 의약분야에서의 응용 |
| CN114787363A (zh) | 2019-10-01 | 2022-07-22 | 恩派瑞安神经科学公司 | 对真菌进行遗传工程化以调节色胺表达 |
| CN113943312A (zh) * | 2020-07-17 | 2022-01-18 | 轶诺(浙江)药业有限公司 | 一类肠道裂解型共药及其制备和用途 |
| CN113200983B (zh) * | 2021-05-22 | 2023-01-03 | 中国药科大学 | 一种吡咯并吡啶结构的化合物、制备方法和医药用途 |
| EP4457336A4 (en) | 2021-12-31 | 2026-01-14 | Empyrean Neuroscience Inc | ORGANISMS GENETICALLY MODIFIED TO PRODUCE PSYCHOTROPIC ALKALOIDS |
| EP4626886A4 (en) * | 2022-12-02 | 2026-03-18 | Onquality Pharmaceuticals China Ltd | JAK inhibitors, pharmaceutical compositions and therapeutic applications |
| CN118459457A (zh) * | 2023-02-08 | 2024-08-09 | 南京羚诺生物医药技术研究院有限公司 | 一种吡咯并吡啶结构的化合物及其制备方法和用途 |
| CN118812508A (zh) * | 2023-04-07 | 2024-10-22 | 原研药港生命科学研究(辽宁)有限公司 | 1-异丙基-1h-吡唑类化合物及药物组合物和应用 |
| WO2025038910A1 (en) * | 2023-08-16 | 2025-02-20 | Aclaris Therapeutics, Inc. | Crystalline polymorph form a of a jak inhibitor and methods for its preparation |
| WO2025144781A1 (en) * | 2023-12-28 | 2025-07-03 | Aclaris Therapeutics, Inc. | Crystalline polymorph of an itk inhibitor |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2141916T3 (es) | 1993-11-30 | 2000-04-01 | Searle & Co | Pirazolil-bencenosulfonamidas sustituidas para el tratamiento de la inflamacion. |
| PA8469501A1 (es) * | 1998-04-10 | 2000-09-29 | Pfizer Prod Inc | Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico |
| PA8474101A1 (es) | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
| WO2000000202A1 (en) | 1998-06-30 | 2000-01-06 | Parker Hughes Institute | Method for inhibiting c-jun expression using jak-3 inhibitors |
| US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| SE0301372D0 (sv) | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Novel compounds |
| AR054416A1 (es) | 2004-12-22 | 2007-06-27 | Incyte Corp | Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas. |
| WO2006127587A1 (en) * | 2005-05-20 | 2006-11-30 | Vertex Pharmaceuticals Incorporated | Pyrrolopyridines useful as inhibitors of protein kinase |
| EP2251341A1 (en) | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclic Janus kinase 3 inhibitors |
| WO2007007919A2 (en) | 2005-07-14 | 2007-01-18 | Astellas Pharma Inc. | Heterocyclic janus kinase 3 inhibitors |
| EP2455382B1 (en) | 2005-12-13 | 2016-10-26 | Incyte Holdings Corporation | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| EP2123651A4 (en) * | 2007-01-12 | 2011-05-04 | Astellas Pharma Inc | CONDENSED PYRIDINE COMPOUND |
| EP3070090B1 (en) | 2007-06-13 | 2018-12-12 | Incyte Holdings Corporation | Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile |
| CL2009001884A1 (es) | 2008-10-02 | 2010-05-14 | Incyte Holdings Corp | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. |
| JP5775070B2 (ja) | 2009-05-22 | 2015-09-09 | インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ | ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体 |
| US9273028B2 (en) * | 2010-10-29 | 2016-03-01 | Biogen Ma Inc. | Heterocyclic tyrosine kinase inhibitors |
| CA2818542A1 (en) | 2010-11-19 | 2012-05-24 | Incyte Corporation | Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
| AU2012295802B2 (en) | 2011-08-12 | 2017-03-30 | Nissan Chemical Industries, Ltd. | Tricyclic heterocyclic compounds and JAK inhibitors |
| MX368464B (es) | 2013-12-05 | 2019-10-02 | Pfizer | Acrilamidas de pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinil o y pirrolo[2,3-d]piridinilo. |
| EP2924026A1 (en) * | 2014-03-28 | 2015-09-30 | Novartis Tiergesundheit AG | Aminosulfonylmethylcyclohexanes as JAK inhibitors |
| CR20160525A (es) | 2014-05-14 | 2016-12-20 | Pfizer | Pirazolopiridinas y pirazolopirimidinas |
| WO2017075363A1 (en) * | 2015-10-30 | 2017-05-04 | Calithera Biosciences, Inc. | Compositions and methods for inhibiting arginase activity |
| WO2017097224A1 (zh) | 2015-12-11 | 2017-06-15 | 四川科伦博泰生物医药股份有限公司 | 氮杂环丁烷衍生物、其制备方法及用途 |
| TW201811795A (zh) | 2016-08-24 | 2018-04-01 | 美商亞闊股份有限公司 | 胺基－吡咯并嘧啶酮化合物及其用途 |
| EP3710431A4 (en) | 2017-11-03 | 2021-07-07 | Aclaris Therapeutics, Inc. | SUBSTITUTED PYRROLOPYRIMIDINE-BASED JAK INHIBITORS AND THEIR MANUFACTURING AND USE PROCEDURES |
| US10800775B2 (en) | 2017-11-03 | 2020-10-13 | Aclaris Therapeutics, Inc. | Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same |
| WO2020033955A1 (en) | 2018-08-10 | 2020-02-13 | Aclaris Therapeutics, Inc. | Pyrrolopyrimidine itk inhibitors |
| KR102737181B1 (ko) * | 2019-03-14 | 2024-12-02 | 상하이 시너지 파마슈티컬 사이언시스 코., 엘티디. | Jak 억제제 및 그 제조방법과 의약분야에서의 응용 |
-
2020
- 2020-05-04 WO PCT/US2020/031332 patent/WO2020223728A1/en not_active Ceased
- 2020-05-04 CN CN202080023588.6A patent/CN113727975A/zh active Pending
- 2020-05-04 EP EP20798983.1A patent/EP3962897A4/en not_active Withdrawn
- 2020-05-04 SG SG11202108927UA patent/SG11202108927UA/en unknown
- 2020-05-04 AU AU2020265828A patent/AU2020265828A1/en not_active Abandoned
- 2020-05-04 MX MX2021013224A patent/MX2021013224A/es unknown
- 2020-05-04 KR KR1020217039379A patent/KR20220004726A/ko not_active Withdrawn
- 2020-05-04 US US16/866,182 patent/US11420966B2/en active Active
- 2020-05-04 CA CA3138544A patent/CA3138544A1/en active Pending
- 2020-05-04 JP JP2021561745A patent/JP2022531088A/ja active Pending
- 2020-05-04 BR BR112021021477A patent/BR112021021477A2/pt not_active Application Discontinuation
- 2020-05-04 PH PH1/2021/552036A patent/PH12021552036A1/en unknown
-
2021
- 2021-08-16 ZA ZA2021/05837A patent/ZA202105837B/en unknown
- 2021-10-31 IL IL287717A patent/IL287717A/en unknown
-
2022
- 2022-06-30 US US17/809,984 patent/US20220372034A1/en not_active Abandoned